Sumit Shah
Overview
Explore the profile of Sumit Shah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
373
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shah S
Colorectal Dis
. 2024 Nov;
27(1):e17242.
PMID: 39545450
Aim: Laparoscopic complete mesocolic excision (CME) with D3 lymphadenectomy for right colon cancer is gaining acceptance. However, this procedure has not yet been standardized like total mesorectal excision. Ergonomics is...
2.
Sfakianos J, Basu A, Laliotis G, Cumarasamy S, Rich J, Kommalapati A, et al.
Eur Urol Oncol
. 2024 Jul;
PMID: 39013741
Background And Objective: Despite curative-intent radical cystectomy (RC), patients with muscle-invasive bladder cancer (MIBC) are at high risk of recurrence. Biomarkers are urgently needed to refine prognostication and selection of...
3.
Rodriguez G, Parikh D, Kapphahn K, Gupta D, Fan A, Shah S, et al.
JAMA Oncol
. 2024 May;
10(7):949-953.
PMID: 38780960
Importance: Advance care planning (ACP) remains low among patients with advanced cancer. Multilevel interventions compared with clinician-level interventions may be more effective in improving ACP. Objective: To evaluate whether a...
4.
Song H, Leonio M, Ferri V, Duan H, Mari Aparici C, Davidzon G, et al.
Eur J Nucl Med Mol Imaging
. 2024 Apr;
51(9):2784-2793.
PMID: 38635050
Purpose: Lutetium-177 [Lu]Lu-PSMA-617 radioligand therapy (RLT) represents a significant advancement for metastatic castration-resistant prostate cancer (mCRPC), demonstrating improvements in radiographic progression free survival (rPFS) and overall survival (OS) with a...
5.
Parikh D, Rodriguez G, Ragavan M, Kerr E, Asuncion M, Hansen J, et al.
Support Care Cancer
. 2024 Feb;
32(3):161.
PMID: 38366165
Purpose: Financial toxicity is a source of significant distress for patients with urologic cancers, yet few studies have addressed financial burden in this patient population. Methods: We developed a financial...
6.
Gajurel B, Yadav S, Nepal G, Pant S, Yadav M, Shah R, et al.
Medicine (Baltimore)
. 2024 Feb;
103(7):e36017.
PMID: 38363915
Neurological symptoms and signs of Coronavirus disease-19 (COVID-19) can accompany, follow, or precede respiratory symptoms and signs; hence, they are important in the diagnosis and management of COVID-19 patients. In...
7.
Molina G, Schwartz B, Srinivas S, Shah S, Zaba L
Eur Urol
. 2023 Jan;
83(4):377-378.
PMID: 36623949
No abstract available.
8.
Gensheimer M, Gupta D, Patel M, Fardeen T, Hildebrand R, Teuteberg W, et al.
JCO Oncol Pract
. 2022 Nov;
19(2):e176-e184.
PMID: 36395436
Purpose: Patients with metastatic cancer benefit from advance care planning (ACP) conversations. We aimed to improve ACP using a computer model to select high-risk patients, with shorter predicted survival, for...
9.
10.
Shibata T, Shah S, Evans T, Coleman H, Lieblong B, Spencer H, et al.
Front Immunol
. 2021 Oct;
12:645299.
PMID: 34659195
Advances in high-throughput sequencing have revolutionized the manner with which we can study T cell responses. We describe a woman who received a human papillomavirus (HPV) therapeutic vaccine called PepCan,...